Home › Research › Treatments
Early Outcomes of Lecanemab for Alzheimer's Disease in the Veterans Health Administration
O'Donnell AJ, Zhao X, Parr A, Aspinall S, Anderson TS.. Journal of clinical medicine, 2025-11-21
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Overall, 32 Veterans (mean [SD] age 75.3 [6.0] years, 100% male, 97% white, 84% urban dwelling) initiated lecanemab. Seventeen patients (53%) had mild cognitive impairment, 15 (47%) had mild dementia; mean baseline MoCA score was 21.3 (SD 3.4). At 7 months following treatment initiation, we assessed process, safety, and effectiveness outcomes. Process In all, 25 patients (78%) were persistent with treatment. Safety Three patients (9%) experienced a stroke, and 7 (22%) experienced ARIA. Effectiveness Only 12 (38%) patients had a MoCA completed by 7 months, and the mean change in MoCA was 0.0 (SD 3.7, p = 1.0). A follow-up amyloid positron emission tomography (PET) scan was completed by 9 (28%) patients, and 5 had reductions in amyloid. Initial observations in a small VHA cohort suggest that uptake of lecanemab was limited, and the finding that nearly 30% of patients experienced ARIA or stroke within 7 months of initiation underscores the importance of monitoring the lecanemab safety and effectiveness long-term. These early findings should be interpreted cautiously given the limited sample size and very limited follow-up MoCA data.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
O'Donnell, A. J., Zhao, X., Parr, A., Aspinall, S., & Anderson, T. S. (2025). Early Outcomes of Lecanemab for Alzheimer's Disease in the Veterans Health Administration. Journal of clinical medicine. https://doi.org/10.3390/jcm14238277
Vancouver
O'Donnell AJ, Zhao X, Parr A, Aspinall S, Anderson TS. Early Outcomes of Lecanemab for Alzheimer's Disease in the Veterans Health Administration. Journal of clinical medicine. 2025. doi:10.3390/jcm14238277. PMID: 41375579.
BibTeX
@article{odonnell2025-41375579,
author = {O'Donnell, A. J. and Zhao, X. and Parr, A. and Aspinall, S. and Anderson, T. S.},
title = {{Early Outcomes of Lecanemab for Alzheimer's Disease in the Veterans Health Administration}},
journal = {Journal of clinical medicine},
year = {2025},
doi = {10.3390/jcm14238277},
pmid = {41375579},
url = {https://doi.org/10.3390/jcm14238277}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Overall, 32 Veterans (mean [SD] age 75.3 [6.0] years, 100% male, 97% white, 84% urban dwelling) initiated lecanemab.
- Seventeen patients (53%) had mild cognitive impairment, 15 (47%) had mild dementia; mean baseline MoCA score was 21.3 (SD 3.4).
- At 7 months following treatment initiation, we assessed process, safety, and effectiveness outcomes.
- Process In all, 25 patients (78%) were persistent with treatment.
- Safety Three patients (9%) experienced a stroke, and 7 (22%) experienced ARIA.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Study designcohort study
- Participants25
- Evidence strengthModerate
How this study scored 67/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 39 of the 58 points we could judge it on, which is 67 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of clinical medicine) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 25 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41375579) |
| Free to read | 2 / 2 | Free to read |
| Points | 39 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 39 of the 58 points we could judge it on is 67 out of 100. |
| Total | 67 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Treatments from nearby years
Also tagged “early”
5 studies in the library carry the topic tag “early”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 5 tagged studies.